Uwell Biopharma, Inc. (TPEX:7902)
45.15
-2.50 (-5.25%)
At close: Apr 17, 2026
478.85% (1Y)
| Market Cap | 9.03B |
| Revenue (ttm) | 450.00K |
| Net Income | -54.86M |
| EPS | -0.47 |
| Shares Out | 200.00M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 480,295 |
| Average Volume | 373,945 |
| Open | 48.30 |
| Previous Close | 47.65 |
| Day's Range | 43.90 - 48.35 |
| 52-Week Range | 7.80 - 51.50 |
| Beta | n/a |
| RSI | 62.31 |
| Earnings Date | n/a |